Qus and answer related to this slide

Reading File
Running Command

cd /tmp/workspace/attachments/bd017b1c-ee2c-4d33-b298-3a374a8329be/ && python3 -c " from pptx import Presentation prs = Presentation('Endo-Nuclear Rounds.pptx') for i, slide in enumerate(prs.slides, 1): print(f'=== SLIDE {i} ===') for shape in slide.shapes: if shape.has_text_frame and shape.text_frame.text.strip(): print(shape.text_frame.text) print() "

Running Command

cd /tmp/workspace/attachments/bd017b1c-ee2c-4d33-b298-3a374a8329be/ && python3 /tmp/skills/pptx/scripts/office/unpack.py "Endo-Nuclear Rounds.pptx" unpacked/

Running Command

ls /tmp/workspace/attachments/bd017b1c-ee2c-4d33-b298-3a374a8329be/unpacked/ppt/media/ 2>/dev/null && echo "---" && ls /tmp/workspace/attachments/bd017b1c-ee2c-4d33-b298-3a374a8329be/unpacked/ppt/slides/

Running Command

python3 -c " from PIL import Image import os base = '/tmp/workspace/attachments/bd017b1c-ee2c-4d33-b298-3a374a8329be/unpacked/ppt/media/' for fname in os.listdir(base): img = Image.open(os.path.join(base, fname)) print(fname, img.size, img.mode) # Save as PNG for easier analysis out = f'/tmp/workspace/{fname.replace(\".tiff\",\".png\")}' img.save(out) print('Saved:', out) "

Reading File
analyse_media
analyse_media
Reading File
Running Command

python3 -c " # Serve images locally via base64 encoding and read XML for any additional data import base64 with open('/tmp/workspace/image1.png','rb') as f: d = base64.b64encode(f.read()).decode() print('image1 b64 len:', len(d)) " # Also read slide XML for any hidden text cat /tmp/workspace/attachments/bd017b1c-ee2c-4d33-b298-3a374a8329be/unpacked/ppt/slides/slide2.xml | python3 -c " import sys, re xml = sys.stdin.read() # Extract all text tags texts = re.findall(r'<a:t>(.*?)</a:t>', xml) print('Slide 2 texts:', texts) " cat /tmp/workspace/attachments/bd017b1c-ee2c-4d33-b298-3a374a8329be/unpacked/ppt/slides/slide3.xml | python3 -c " import sys, re xml = sys.stdin.read() texts = re.findall(r'<a:t>(.*?)</a:t>', xml) print('Slide 3 texts:', texts) " cat /tmp/workspace/attachments/bd017b1c-ee2c-4d33-b298-3a374a8329be/unpacked/ppt/slides/slide4.xml | python3 -c " import sys, re xml = sys.stdin.read() texts = re.findall(r'<a:t>(.*?)</a:t>', xml) print('Slide 4 texts:', texts) "

Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Finding Sources
Here is a comprehensive Q&A based on the Endo-Nuclear Rounds slide (Dr. Saurabh Tanwar, PG1 Nuclear Medicine) - a case of a 69-year-old male with a right neck swelling and hyper-functioning thyroid adenoma on ⁹⁹ᵐTc scintigraphy.

Clinical Case Summary

Patient: Mr. Roop Singh | 69 years | Male | ID: 202607032240 Presentation: Right-sided neck swelling x 3 years Investigations:
  • USG neck: Benign thyroid nodule (right lobe)
  • CECT neck: Hypodense solid benign thyroid nodule (right lobe)
  • TFT: T3 = 3.6 ng/ml, T4 = 10.9 µg/dl, TSH < 0.01 µIU/ml (suppressed)
  • ⁹⁹ᵐTc thyroid scintigraphy: Increased perfusion and function, enlarged right lobe
Impression: Hyper-functioning Thyroid Adenoma

Q&A


Q1. What is a hyper-functioning (toxic) thyroid adenoma?

A: A toxic thyroid adenoma is an autonomously functioning thyroid neoplasm - a solitary nodule that produces thyroid hormones independent of TSH stimulation. About 20% of patients present with overt thyrotoxicosis and another 20% have subclinical thyrotoxicosis at diagnosis. The nodule is usually 3 cm or more in diameter. Hyperfunctioning or autonomous thyroid nodules typically need to attain at least 3 cm before overt hyperthyroidism occurs.
(Cummings Otolaryngology, p. 2499; Schwartz's Principles of Surgery, 11e)

Q2. What is the characteristic finding on ⁹⁹ᵐTc scintigraphy in a toxic adenoma?

A: Radionuclide uptake imaging shows:
  • Intense "hot" tracer concentration at the site of the autonomous nodule
  • Near-complete suppression (absence of uptake) in the rest of the thyroid gland - because the autonomous nodule suppresses TSH, which in turn suppresses function in the contralateral/normal thyroid tissue
This pattern is called a "hot nodule" and is almost always benign with extremely low risk of malignancy. In contrast, a "cold nodule" (photopenia) was historically suspicious for malignancy, though FNA biopsy is now the gold standard.
(Mulholland and Greenfield's Surgery, 7e; Cummings Otolaryngology)

Q3. Why is ⁹⁹ᵐTc pertechnetate used for thyroid scintigraphy and what are its key properties?

A:
  • ⁹⁹ᵐTc pertechnetate is rapidly absorbed/trapped by thyroid follicular cells (like iodide), but unlike iodine, it is not incorporated into thyroglobulin
  • Emits primarily gamma (γ) radiation - ideal for external detection
  • Scintigraphy must be performed within 20-30 minutes after injection due to rapid washout
  • It delineates function but does not delineate anatomy well
(Mulholland and Greenfield's Surgery, 7e)

Q4. What does a suppressed TSH (< 0.01 µIU/ml) tell us in the context of this case?

A: A suppressed TSH confirms autonomous thyroid hormone production. The hyper-functioning adenoma produces T3 and T4 independent of TSH. The elevated hormone levels feed back to suppress TSH from the pituitary. This is the biochemical hallmark of:
  • Overt or subclinical hyperthyroidism
  • Autonomous nodule (toxic adenoma) or toxic multinodular goiter
In this case (T3 3.6, T4 10.9 with TSH < 0.01), the patient has overt biochemical hyperthyroidism driven by the autonomous nodule.
(Tietz Textbook of Laboratory Medicine, 7e; Scott-Brown's ORL)

Q5. How does thyroid scintigraphy differentiate causes of thyrotoxicosis?

A:
ConditionScintigraphic Pattern
Toxic adenomaSingle "hot" nodule; rest of gland suppressed
Toxic multinodular goiter (TMNG)Multiple heterogeneous "hot" foci
Graves' diseaseDiffuse, symmetrically increased uptake throughout gland
Thyroiditis (subacute/silent)Diffusely decreased/absent uptake
Iodine-induced hyperthyroidismLow uptake
(Scott-Brown's ORL, Vol 1; Swanson's Family Medicine)

Q6. Why is a "hot nodule" considered benign?

A: A hot nodule concentrates the radiotracer avidly, indicating active metabolic function. Well-differentiated thyroid malignancies rarely retain full iodine-trapping and hormone-producing capacity - they lose this function as they dedifferentiate. Therefore, a hyperfunctioning "hot" nodule has extremely low risk of malignancy and FNA biopsy is generally not indicated for hot nodules.
(Mulholland and Greenfield's Surgery, 7e)

Q7. What are the management options for a toxic thyroid adenoma?

A: Management is required because the thyrotoxicosis is usually permanent (unlike Graves' disease which can remit). Options include:
  1. Radioactive Iodine (¹³¹I) ablation - Most common; effective. Carries a slight-to-moderate risk of transient or permanent hypothyroidism afterward, but this can be minimized with appropriate dosing.
  2. Surgical resection (thyroid lobectomy) - Definitive; generally no recurrence of thyrotoxicosis or hypothyroidism. Performed after 4-6 weeks of antithyroid drugs + Lugol's solution (7-10 days) pre-operatively. Complications are rare.
  3. Percutaneous ethanol injection (PEI) - More common in Europe; ultrasound-guided injection into the adenoma. Safe long-term, but may need multiple sessions. Suitable for patients who are poor surgical candidates or refuse radioiodine.
  4. Antithyroid drugs (e.g., methimazole/PTU) - Used for pre-operative preparation, NOT definitive treatment.
(Cummings Otolaryngology, pp. 2503-2507)

Q8. What is the significance of the CECT showing a hypodense solid nodule in this case?

A: A hypodense solid nodule on CECT in the right thyroid lobe is consistent with a thyroid adenoma. The scintigraphic finding of increased tracer uptake at this site correlates with the CECT anatomy, confirming the nodule is the source of autonomous function. This anatomical-functional correlation is the key strength of combining cross-sectional imaging (CECT/USG) with nuclear medicine scintigraphy.
Note: CECT iodinated contrast can interfere with subsequent radioiodine therapy (iodine pool saturation). This is an important consideration when planning ¹³¹I therapy.

Q9. What are the phases seen on a two-phase ⁹⁹ᵐTc thyroid scan (perfusion + static)?

A: In ⁹⁹ᵐTc thyroid scintigraphy with perfusion study:
  • Phase 1 (Perfusion/Flow phase): Dynamic images capture arterial inflow. Increased perfusion to the right lobe (as in this case) reflects hypervascularity of the functioning adenoma.
  • Phase 2 (Static/Uptake phase): Images at 20-30 min post-injection show functional uptake. The hot nodule is clearly demarcated with suppression of surrounding thyroid tissue.
Together, increased perfusion + increased uptake = hyper-functioning adenoma pattern.

Q10. What is subclinical vs. overt hyperthyroidism in the context of a toxic adenoma?

A:
  • Subclinical hyperthyroidism: TSH suppressed but T3 and T4 remain within the normal range. No overt symptoms. About 20% of toxic adenoma patients present this way.
  • Overt hyperthyroidism: TSH suppressed + elevated T3/T4 with clinical symptoms (palpitations, weight loss, tremor, heat intolerance). About 20% of toxic adenoma patients present this way.
In this patient, TSH < 0.01 with T3 3.6 ng/ml (elevated, normal ~0.8-2.0 ng/ml) and T4 10.9 µg/dl suggests overt biochemical hyperthyroidism.
Over time, subclinical cases tend to progress to overt hyperthyroidism - particularly in patients with autonomous nodules or multinodular goiter.
(Tietz Textbook of Laboratory Medicine, 7e; Cummings Otolaryngology)

Q11. What is the role of USG in evaluating this case?

A: Ultrasound (USG) is the first-line structural imaging for thyroid nodules. In this case USG reported a "benign thyroid nodule." USG provides:
  • Size, echogenicity, margins, vascularity (Doppler)
  • TIRADS (Thyroid Imaging Reporting and Data System) classification for malignancy risk
  • Guidance for FNA biopsy if indicated
However, USG cannot assess function. That is the role of scintigraphy. For a hot nodule confirmed on scintigraphy, FNA is generally not required as the malignancy risk is negligible.

Q12. What is the differential diagnosis for a unilateral hot nodule on thyroid scintigraphy?

A:
  1. Toxic adenoma (most common - as in this case)
  2. Dominant nodule in early TMNG (other areas may show residual uptake)
  3. Lingual thyroid or ectopic thyroid tissue (if scan shows uptake outside normal position)
  4. Functioning thyroid cancer metastasis (rare, usually "cold" on pertechnetate)
The combination of a single suppressed TSH, solitary palpable nodule, and focal hot area with suppression of the rest of the gland clinches toxic adenoma.

Sources: Cummings Otolaryngology Head and Neck Surgery; Mulholland and Greenfield's Surgery 7e; Scott-Brown's ORL Vol 1; Schwartz's Principles of Surgery 11e; Tietz Textbook of Laboratory Medicine 7e
This is a shared conversation. Sign in to Orris to start your own chat.